Reagan-Udall Launches Real-Word Evidence Collaboration For Sickle Cell Disease

FDA's Regan-Udall Foundation and the ASH Research Collaborative (ASH RC) are launching a collaborative project to gather real-world evidence for sickle cell disease, aiming to establish a consensus on using electronic health record data to better understand clinical outcomes among sickle cell patients and broaden research in the field. The "Real-World Evidence Consortium” will be a collaboration among clinicians, researchers, patients, federal regulators, informaticians and other industry stakeholders, according to the statement announcing the effort Wednesday (April 17). In electronic...